» Articles » PMID: 15665052

Platelet-activating Factor Increases Endothelial [Ca2+]i and NO Production in Individually Perfused Intact Microvessels

Overview
Date 2005 Jan 25
PMID 15665052
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

We have demonstrated that inhibition of NO synthase (NOS) in endothelial cells by either the NOS inhibitor N(omega)-monomethyl-l-arginine (l-NMMA) or the internalization of caveolin-1 scaffolding domain attenuated platelet-activating factor (PAF)-induced increases in microvessel permeability (Am J Physiol Heart Circ Physiol 286: H195-H201, 2004) indicating the involvement of an NO-dependent signaling pathway. To investigate whether an increase in endothelial cytoplasmic Ca(2+) concentration ([Ca(2+)](i)) is the initiating event and Ca(2+)-dependent NO production is crucial for permeability increases, PAF (10 nM)-induced changes in endothelial [Ca(2+)](i) and NO production were measured in individually perfused rat mesenteric venular microvessels via fluorescence microscopy. When venular microvessels were exposed to PAF, endothelial [Ca(2+)](i) increased from 69 +/- 8 nM to a peak value of 374 +/- 26 nM within 3 min and then declined to a sustained level at 190 +/- 12 nM after 15 min. Inhibition of NOS did not modify PAF-induced increases in endothelial [Ca(2+)](i). PAF-induced NO production was visualized and quantified at cellular levels in individually perfused microvessels using 4,5-diaminofluorescein diacetate and fluorescence imaging. Increased fluorescence intensity (FI), which is an indication of increased NO production, occurred in 75 +/- 7% of endothelial cells in each vessel. The mean maximum FI increase was 140 +/- 7% of baseline value. This increased FI was abolished by pretreatment of the vessel with l-NMMA and attenuated in the absence of extracellular Ca(2+). These results provide direct evidence from intact microvessels that increased endothelial [Ca(2+)](i) is the initial signal that activates endothelial NOS, and the subsequent increased NO production contributes to PAF-induced increases in microvessel permeability.

Citing Articles

Endothelial mechanobiology in atherosclerosis.

Wang X, Shen Y, Shang M, Liu X, Munn L Cardiovasc Res. 2023; 119(8):1656-1675.

PMID: 37163659 PMC: 10325702. DOI: 10.1093/cvr/cvad076.


Leveraging avidin-biotin interaction to quantify permeability property of microvessels-on-a-chip networks.

Gao F, Sun H, Li X, He P Am J Physiol Heart Circ Physiol. 2021; 322(1):H71-H86.

PMID: 34767485 PMC: 8698539. DOI: 10.1152/ajpheart.00478.2021.


Oxidative Stress and Microvessel Barrier Dysfunction.

He P, Talukder M, Gao F Front Physiol. 2020; 11:472.

PMID: 32536875 PMC: 7268512. DOI: 10.3389/fphys.2020.00472.


H O -induced microvessel barrier dysfunction: the interplay between reactive oxygen species, nitric oxide, and peroxynitrite.

Zhou X, Qian Y, Yuan D, Feng Q, He P Physiol Rep. 2019; 7(16).

PMID: 31448579 PMC: 6709418. DOI: 10.14814/phy2.14206.


Increased circulating microparticles in streptozotocin-induced diabetes propagate inflammation contributing to microvascular dysfunction.

Feng Q, Stork C, Xu S, Yuan D, Xia X, LaPenna K J Physiol. 2018; 597(3):781-798.

PMID: 30548258 PMC: 6355626. DOI: 10.1113/JP277312.